Earth Science Tech Inc. (OTC: ETST) is leveraging a diversified, vertically integrated business model spanning pharmaceuticals, telemedicine, retail and real estate to drive revenue growth and product expansion. Through subsidiaries including Peak Curative, RxCompound and Mister Meds, the company connects telemedicine consultations, compounding pharmacies and medication fulfillment within an end-to-end healthcare ecosystem. Its MOCTeledoc platform also provides B2B technology and clinical staffing solutions, allowing ETST to generate revenue by supporting other digital health companies while expanding its own reach.
The integrated model supports product development and diversification, contributing to fiscal 2026 revenue growth of 8%, alongside increases in gross profit and net income. According to the full article, the company’s value proposition centers on seamless integration of patient care from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. The company’s principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company’s healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
This vertical integration is critical as it allows ETST to capture margins across multiple stages of the healthcare delivery chain, from virtual consultations to medication dispensing. By owning the infrastructure, the company reduces dependency on third-party providers and can better control quality and patient experience. The B2B offering through MOCTeledoc further diversifies revenue streams by providing technology and staffing solutions to other digital health companies, creating a recurring revenue component.
The 8% revenue growth in fiscal 2026 is particularly noteworthy given the competitive landscape of digital health and compounding pharmacies. It suggests that the integrated model is gaining traction and that the company is effectively cross-selling services across its subsidiaries. For investors, the increase in gross profit and net income indicates improving operational efficiency and scalability.
For more information about Earth Science Tech, visit www.EarthScienceTech.com and the company’s newsroom at https://ibn.fm/ETST.
